Self-insured employers may be leaving money on the table by not regularly evaluating pharmacy benefits

coapharm2020-09-29T14:30:45+00:00September 29, 2020|

HRSA Issues Proposed Rule Requiring Community Health Center Grant Recipients to Provide Certain Drugs to Low-Income Patents at 340B Prices

coapharm2020-09-29T14:29:54+00:00September 29, 2020|

Drug prices: Why prescription medicines remain unaffordable for many Americans

coapharm2020-09-29T14:28:27+00:00September 29, 2020|

Big Pharma Backs Joe Biden, But People Don’t Think He’ll Fix Drug Pricing

coapharm2020-09-29T14:27:00+00:00September 29, 2020|

340B UPDATE: Congress and the Administration Respond to Drug Manufacturers’ 340B Contract Pharmacy Actions

coapharm2020-09-28T13:09:24+00:00September 28, 2020|

Average International Market Pricing For US Pharmaceuticals—Lessons From Europe

coapharm2020-09-28T13:08:24+00:00September 28, 2020|

The Impact Of The COVID-19 Pandemic On Hospital Admissions In The United States

coapharm2020-09-28T13:07:34+00:00September 28, 2020|

PBM “Reforms” Leave Biosimilars Out in the Cold

coapharm2020-09-25T16:40:15+00:00September 25, 2020|

HHS slows community health center 340B discounts rule

coapharm2020-09-25T16:38:25+00:00September 25, 2020|

Sticker Shock in the Pharmacy

coapharm2020-09-24T16:00:27+00:00September 24, 2020|